Intracranial meningiomas: diagnosis and treatment

References

• Longstreth WT, Dennis LK, McGuire VM et al. Epidemiology of intracranial meningioma. Cancer 72, 639–648 (1993).
   PubMed Web of Science ®Google Scholar
• Wilson CB, Meningiomas: genetics, malignancy and the role of radiation in induction and treatment. j Neurosurg. 81, 666–675 (1994).
   PubMed Web of Science ®Google Scholar
• ••Excellent review of meningioma with the emphasis on surgery and radiotherapy.
   Google Scholar
• Bondy M, Ligon BL. Epidemiology and etiology of intracranial meningiomas; a review. Neum-oncol 29,197–205 (1996).
   PubMedGoogle Scholar
• De Monte E Current management of meningiomas. Oncology9 (1), 83–92 (1995).
   Google Scholar
• ••Excellent review of contemporarytreatment of meningioma.
   Google Scholar
• Sanson M, Comu P Biology of meningiomas. Acta Neurochir (Wien). 142, 493–505 (2000).
   PubMed Web of Science ®Google Scholar
• Mirimanoff RO, Dosoretz DE, Linggood RM et al Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg. 62, 18–24 (1985).
   PubMed Web of Science ®Google Scholar
• Jaaskelainen J. Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients: a multivariate analysis. Surg: Neural 26,261–469 (1986).
   Google Scholar
• Goldsmith BJ, Wara WM, Wilson CB, Larson DA. Postoperative irradiation for subtotally resected meningiomas. Neurosurg. 80,195–201 (1994).
   Google Scholar
• Lunsford DL. Contemporary management of meningiomas: radiation therapy as an adjuvant and radiosurgery as an alternative to surgical removal?' Neurosurg: 80, 187–190 (1994).
   Google Scholar
• Kondziolka D, Lunsford D, Coffey RJ, Flickinger JC. Stereotactic radiosurgery of meningiomas. I Neurosurg: 74,552–559 (1991).
   PubMed Web of Science ®Google Scholar
• Morita A, Coffey RJ, Foote RL, Schiff D, Gorman D. Risk of injury to cranial nerves after gamma knife radiosurgery for skull base meningiomas: experience in 88 patients. Neurosurg. 90,42-50 (1999).
   Google Scholar
• Lee JYK, Niranjan A, McInerney J, Kondziolka D, Flickinger J, Lundsford LD. Stereotactic radiosurgery providing long-term control of cavernous sinus meningiomas. I Aiumsurg. 97,65–72 (2002).
   Google Scholar
• Ojemann SG, Sneed PK, Larson DH etal Radiosurgery for malignant meningioma: results in 22 patients. I Neurosurg: 93\(Suppl. 3), 62–67 (2000).
   Google Scholar
• Flickinger JC, Kondziolka D eta]. Gamma knife radiosurgery of imaging-diagnosed intracranial meningioma. Int. J Radiation Oncology Biol. Phys. 56(3), 801–806 (2003).
   Google Scholar
• ••Contemporary review of radiosurgery for newly diagnosed meningioma.
   Google Scholar
• McLaren F, Black P Hormones, radiosurgery and virtual reality: new aspects of meningioma management. Can. J Neural Sci. 24,302–306 (1997).
   PubMedGoogle Scholar
• Kyritisis AP. Chemotherapy for meningiomas. j Neuro-oncol 29,269–272 (1996).
   PubMedGoogle Scholar
• Grunberg SM, Rankin C, Townsend C et at. Phase III double-blind randomized placebo-controlled study of mifepristone (RU-486). For the treatment of unresectable meningioma. Proc. Am. Soc. Clin. Oncol 20,56 (2001).
   Google Scholar
• Kaba SE, DeMonte F, Bruner JM etal The treatment of recurrent unresectable and malignant meningiomas with interferon a-2b. Neurosurgery40, 271–275 (1997).
   PubMed Web of Science ®Google Scholar
• Schrell UMH, Rittig MG, Anders M etal Hydroxyurea for the treatment of unresectable and recurrent meningiomas. Neurosurg. 86,845–852 (1997).
   Google Scholar
• Mason WP, Gentili F, Macdonald DR, Hariharan S, Cruz CR, Abrey LE. Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma. I Neurosurg: 97, 341–346 (2002).
   PubMed Web of Science ®Google Scholar
• Grunberg SM, Weiss M. Lack of efficacy of megestrol acetate in the treatment of unresectable meningioma. I Neum-oncol 8,61–65 (1990).
   PubMed Web of Science ®Google Scholar
• Grunberg SM, Weiss MET, Spitz IM eta]. Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. Neumsurg. 74,861–866 (1991).
   Google Scholar
• Wober-Bringöl c, Wober C, Marosi C, Prayer D. Interferon-a-2b for meningioma. Lancet345, 331 (1995).
   Google Scholar
• DeMonte F, Bruner JM, Kyritsis AP, Jaeckle IKA, Levin V, Yung A. The treatment of recurrent unresectable and malignant meningiomas with interferon-a-2b. Neurosurg. 86,271–275 (1997).
   Google Scholar
• Chamberlain MC. Malignant meningiomas: adjunct combined modality therapy. J. Neurosurg. 84,733–736 (1996).
   PubMedGoogle Scholar
• Ljunggren B. The case of general wood. J. Neurosurg. 56(4), 471–474 (1982).
   PubMedGoogle Scholar
• Phillips LE, Koepsell TD, van Belle G eta]. History of head trauma and risk of intracranial meningioma: population-based case-control study. Neurology 58, 1849–1852 (2002).
   PubMedGoogle Scholar
• Baumgartner JE, Sorenson JM. Meningioma in the pediatric population. J. Neuro-oncol 29,223–228 (1996).
   PubMedGoogle Scholar
• Blumenthal D, Berho M, Bloomfield S, Schochet SS Jr, Kaufman HK. Childhood meningioma associated with meningioangiomatosis. I Neurosurg. 78, 287–289 (1993).
   Google Scholar
• MUCCiOli G, Ghe C, Faccani G, Lanotte M, Forth M, Ciccarelli E. Prolactin receptors in human meningiomas: characterization and biological role. J. Endocrinal 153,365–3731 (1997).
   PubMed Web of Science ®Google Scholar
• Jhawar BS, Fuchs CS, Colditz GA etal Sex steroid hormone exposures and risk for meningioma. I Neurosurg: 99,848–853 (2003).
   PubMed Web of Science ®Google Scholar
• Jimenez-Hakim E, el-Azouzi M, Black PM. The effect of prolactin and bombesin on the growth of meningioma-derived cells in monolayer culture. J. Neuro-oncol 16, 185–190 (1993).
   Google Scholar
• Osborne Anne G. Meningiomas and other nonglial neoplasms. In: Diagnostic Neuroradiology Mosby Year Book Inc. MO, USA, 14,579–625 (1994).
   Google Scholar
• ••Excellent resource for the radiology ofmeningioma.
   Google Scholar
• Gutman DH, Donahoe J, Perry A. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Hum. Mal Genet. 9,1495-1500 (2000).
   Google Scholar
• •Overview of the molecular genetics of meningioma.
   Google Scholar
• Antinheimo J, Sankila R, Carpen 0 etal Population-based analysis of sporadic and Type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 54,71–78 (2000).
   PubMed Web of Science ®Google Scholar
• Sadetzki S, Flint-Richter P, Ben-Tal T, Nass D. Radiation-induced meningioma: a descriptive study. J. Neurosurg: 97, 1078–1082 (2002).
   PubMed Web of Science ®Google Scholar
• King A, Gutmann DH. The question of familial meningiomas and schwannomas. Neurology54, 4–5 (2000).
   PubMedGoogle Scholar
• Ho D M-T, Hsu CY, Ting LT, Chiang H. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer 94(5), 1538–1547 (2002).
   Google Scholar
• Yamasaki F, Yoshioka H, Hama S etal Recurrence of meningiomas. Influence of vascular endothelial growth factor expression. Cancer 89 (5), 1102–1110 (2000).
   PubMedGoogle Scholar
• Cobb MA, Husain M, Andersen BJ, Al- Mefty 0. Significance of proliferating cell nuclear antigen in predicting recurrence of intracranial meningioma. I Neumsurg. 84, 85–90 (1996).
   Google Scholar
• Magrassi L, De-Fraga C, Conti L et al Expression of the JAK and STAT superfamilies in human meningiomas. Neurosurg. 91,440–446 (1999).
   Google Scholar
• Olivero WC, Lister JR, Elwood PW. The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients.j Neurosurg. 83,222-224 (1995).
   Google Scholar
• Braunstein JB, Vick NA: Meningiomas: the decision not to operate. Neurology 48, 1459–1462 (1997).
   PubMedGoogle Scholar
• •Overview on the need for surgery and the natural history of untreated meningioma.
   Google Scholar
• Firsching RP, Fischer A, Peters R, Thun F, Klug N. Growth rate of incidental meningiomas. I Neurosurg. 73,545–547 (1990).
   Google Scholar
• Go RS, Taylor BV, Kimmel DW. The natural history of asymptomatic meningiomas in Olmsted County, Minnesota. Neumlogy51,1718–1720 (1998).
   Google Scholar
• Niiro M, Yatsushiro K, Nakamura K, Yoshihiro K, Kuratsu J. Natural history of elderly patients with asymptomatic meningiomas. I Neural Neurosurg. Psych. 68 (1), 25–28 (2000).
   Google Scholar
• Goodwin JW, Crowley J, Eyre HJ etal A Phase II evaluation of tamoxifen unresectable or refractory meningiomas: a Southwest Oncology Group Study. Neuro-oncol 15,73–77 (1993).
   Google Scholar
• Herbert B, Stevens MA. Hydroxyurea chemotherapy for unresectable or residual meningioma. I Neuro-oncol 49 (2), 165–170 (2000).
   PubMedGoogle Scholar
• •A single institutions experience with the most effective chemotherapy reported for recurrent meningioma.
   Google Scholar
• Jensen RL, Origitano TC, Lee YS, Weber M, Wurster RD. In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists. Neumsurgety36, 365–374 (1995).
   Google Scholar
• Chamberlain MC, Tsao-Wei D, Groshen S. Temozolomide for treatment resistant recurrent meningioma. Neurology 62 (7), 1210–1212 (2004).
   PubMed Web of Science ®Google Scholar